NM_001172303.3:c.2139G>A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001172303.3(MASTL):​c.2139G>A​(p.Gln713Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0167 in 1,614,040 control chromosomes in the GnomAD database, including 331 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 22 hom., cov: 31)
Exomes 𝑓: 0.017 ( 309 hom. )

Consequence

MASTL
NM_001172303.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0870

Publications

3 publications found
Variant links:
Genes affected
MASTL (HGNC:19042): (microtubule associated serine/threonine kinase like) This gene encodes a microtubule-associated serine/threonine kinase. Mutations at this locus have been associated with autosomal dominant thrombocytopenia, also known as thrombocytopenia-2. Alternatively spliced transcript variants have been described for this locus. [provided by RefSeq, Feb 2010]
ACBD5 (HGNC:23338): (acyl-CoA binding domain containing 5) This gene encodes a member of the acyl-Coenzyme A binding protein family, known to function in the transport and distribution of long chain acyl-Coenzyme A in cells. This gene may play a role in the differentiation of megakaryocytes and formation of platelets. A related protein in yeast is involved in autophagy of peroxisomes. A mutation in this gene has been associated with autosomal dominant thrombocytopenia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
ACBD5 Gene-Disease associations (from GenCC):
  • retinal dystrophy with leukodystrophy
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • acyl-CoA binding domain containing protein 5 deficiency
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 10-27173132-G-A is Benign according to our data. Variant chr10-27173132-G-A is described in ClinVar as Benign. ClinVar VariationId is 262119.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.087 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0119 (1817/152242) while in subpopulation SAS AF = 0.0336 (162/4820). AF 95% confidence interval is 0.0294. There are 22 homozygotes in GnomAd4. There are 884 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 1817 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MASTLNM_001172303.3 linkc.2139G>A p.Gln713Gln synonymous_variant Exon 9 of 12 ENST00000375940.9 NP_001165774.1 Q96GX5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MASTLENST00000375940.9 linkc.2139G>A p.Gln713Gln synonymous_variant Exon 9 of 12 1 NM_001172303.3 ENSP00000365107.5 Q96GX5-1

Frequencies

GnomAD3 genomes
AF:
0.0120
AC:
1818
AN:
152124
Hom.:
22
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00268
Gnomad AMI
AF:
0.104
Gnomad AMR
AF:
0.00373
Gnomad ASJ
AF:
0.0156
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0336
Gnomad FIN
AF:
0.0232
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0156
Gnomad OTH
AF:
0.0110
GnomAD2 exomes
AF:
0.0159
AC:
3989
AN:
251404
AF XY:
0.0178
show subpopulations
Gnomad AFR exome
AF:
0.00295
Gnomad AMR exome
AF:
0.00376
Gnomad ASJ exome
AF:
0.0178
Gnomad EAS exome
AF:
0.000217
Gnomad FIN exome
AF:
0.0238
Gnomad NFE exome
AF:
0.0160
Gnomad OTH exome
AF:
0.0173
GnomAD4 exome
AF:
0.0171
AC:
25069
AN:
1461798
Hom.:
309
Cov.:
31
AF XY:
0.0181
AC XY:
13132
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.00257
AC:
86
AN:
33478
American (AMR)
AF:
0.00425
AC:
190
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0166
AC:
434
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39696
South Asian (SAS)
AF:
0.0383
AC:
3303
AN:
86250
European-Finnish (FIN)
AF:
0.0272
AC:
1454
AN:
53418
Middle Eastern (MID)
AF:
0.0324
AC:
187
AN:
5768
European-Non Finnish (NFE)
AF:
0.0166
AC:
18465
AN:
1111932
Other (OTH)
AF:
0.0157
AC:
947
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1248
2496
3743
4991
6239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
712
1424
2136
2848
3560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0119
AC:
1817
AN:
152242
Hom.:
22
Cov.:
31
AF XY:
0.0119
AC XY:
884
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.00267
AC:
111
AN:
41556
American (AMR)
AF:
0.00373
AC:
57
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0156
AC:
54
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5180
South Asian (SAS)
AF:
0.0336
AC:
162
AN:
4820
European-Finnish (FIN)
AF:
0.0232
AC:
246
AN:
10600
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0156
AC:
1063
AN:
68012
Other (OTH)
AF:
0.0109
AC:
23
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
89
177
266
354
443
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0144
Hom.:
9
Bravo
AF:
0.00976
Asia WGS
AF:
0.0130
AC:
45
AN:
3478
EpiCase
AF:
0.0156
EpiControl
AF:
0.0159

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Thrombocytopenia Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
0.48
DANN
Benign
0.63
PhyloP100
0.087
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41282228; hg19: chr10-27462061; COSMIC: COSV107426213; API